MWVC
Morgens Waterfall Vintiadis & Co Portfolio holdings
AUM
$136M
This Quarter Return
-17.62%
1 Year Return
+103.3%
3 Year Return
+567.71%
5 Year Return
+1,003.82%
10 Year Return
+9,424.15%
AUM
$112M
AUM Growth
+$112M
(-26%)
Cap. Flow
-$18.7M
Cap. Flow
% of AUM
-16.69%
Top 10 Holdings %
Top 10 Hldgs %
38.04%
Holding
75
New
19
Increased
7
Reduced
10
Closed
16
Top Buys
| 1 |
ON Semiconductor
ON
|
$3.47M |
| 2 |
MongoDB
MDB
|
$2.72M |
| 3 |
Trade Desk
TTD
|
$2.67M |
| 4 |
Domino's
DPZ
|
$2.65M |
| 5 |
American Eagle Outfitters
AEO
|
$2.65M |
Top Sells
| 1 |
XYZ
Block, Inc.
XYZ
|
$7.43M |
| 2 |
XPO
XPO
|
$5.94M |
| 3 |
Caesars Entertainment
CZR
|
$5.64M |
| 4 |
Teladoc Health
TDOC
|
$3.89M |
| 5 |
Alibaba
BABA
|
$3.79M |
Sector Composition
| 1 | Technology | 37.29% |
| 2 | Consumer Discretionary | 24.58% |
| 3 | Healthcare | 12.17% |
| 4 | Communication Services | 9.72% |
| 5 | Industrials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
UnitedHealth
UNH
$281B
| $2.49M | 2.22% |
10,000
-100
| -1% | -$24.9K |
|
27
Boeing
BA
$177B
| $2.45M | 2.18% |
+7,600
| New | +$2.45M |
|
28
Home Depot
HD
$405B
| $1.82M | 1.62% |
10,600
| – | – |
|
|
RETA
29
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.8M | 1.6% |
32,000
| – | – |
|
30
Illumina
ILMN
$15.8B
| $1.5M | 1.33% |
5,000
| – | – |
|
31
eHealth
EHTH
$118M
| $1.5M | 1.33% |
39,000
| – | – |
|
32
Visa
V
$683B
| $1.32M | 1.17% |
10,000
+5,000
| +100% | +$660K |
|
|
VCRA
33
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $1.24M | 1.1% |
31,500
-9,500
| -23% | -$374K |
|
34
Mastercard
MA
$538B
| $1.23M | 1.09% |
6,500
| – | – |
|
|
BEAT
35
DELISTED
BioTelemetry, Inc.
BEAT
| $1.11M | 0.98% |
18,500
| – | – |
|
|
MDSO
36
DELISTED
Medidata Solutions, Inc.
MDSO
| $1.04M | 0.92% |
15,400
| – | – |
|
|
TRHC
37
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $1.02M | 0.91% |
16,000
| – | – |
|
38
Heron Therapeutics
HRTX
$207M
| $1.01M | 0.9% |
39,000
| – | – |
|
39
ADMA Biologics
ADMA
$4.12B
| $956K | 0.85% |
400,000
+25,000
| +7% | +$59.8K |
|
40
Salesforce
CRM
$245B
| $685K | 0.61% |
+5,000
| New | +$685K |
|
41
Walt Disney
DIS
$213B
| $658K | 0.59% |
+6,000
| New | +$658K |
|
42
Abbott
ABT
$231B
| $651K | 0.58% |
+9,000
| New | +$651K |
|
43
Apple
AAPL
$3.45T
| $631K | 0.56% |
4,000
-1,938
| -33% | -$306K |
|
44
Southern Company
SO
$102B
| $615K | 0.55% |
+14,000
| New | +$615K |
|
45
Omnicell
OMCL
$1.5B
| $612K | 0.54% |
+10,000
| New | +$612K |
|
46
Pfizer
PFE
$141B
| $567K | 0.5% |
13,000
| – | – |
|
47
AstraZeneca
AZN
$248B
| $490K | 0.44% |
12,900
+700
| +6% | +$26.6K |
|
48
Merck
MRK
$210B
| $477K | 0.42% |
+6,240
| New | +$477K |
|
49
BP
BP
$90.8B
| $475K | 0.42% |
12,532
| – | – |
|
|
RDS.B
50
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $467K | 0.42% |
7,792
| – | – |
|